Clinical Trials List
2026-01-27 - 2030-12-31
Phase II
Recruiting7
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 侯宜廷 Division of Ophthalmology
- 陳柏邑 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- 莊建淮 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-Jui Yen Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- Wei-Lun Chang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳煥武 Division of Radiology
- Chun-Hsiu Liu Division of Ophthalmology
- Yung-Chia Kao Division of General Internal Medicine
- 張鈞弼 Division of Radiology
- Chan-Keng Yang Division of General Internal Medicine
- Po-Jung Su Division of General Internal Medicine
- Ming-Mo Hou Division of General Internal Medicine
- Mengting Peng Division of General Internal Medicine
- Chia-Hsun Hsieh Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ta-Ching Chen Division of Ophthalmology
- Chia-Chi Lin Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
- 莊建淮 Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李易濰 Division of Radiology
- 郭明濬 Division of General Internal Medicine
- 蔡宗翰 Division of General Internal Medicine
- Tai-Jan Chiu Division of General Internal Medicine
- 黃詩喻 Division of General Internal Medicine
- 吳佳哲 Division of General Internal Medicine
- 林偉哲 Division of Radiology
- 黃泰霖 Division of General Internal Medicine
- 林昶廷 Division of General Internal Medicine
- 陳彥豪 Division of General Internal Medicine
- Yu-Li Su Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 唐振育 Division of Hematology & Oncology
- 陳宥任 Division of General Internal Medicine
- Yi-Ping Hung Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- 翁敬堯 Division of Radiology
- 黃宣恩 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王幸婷 Division of General Internal Medicine
- Chi-Ching Chen Division of General Internal Medicine
- Ming-Yu Lien Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
17 participants
-
Global
60 participants
